Bio-Rad Laboratories Inc
Company Profile
Business description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Contact
1000 Alfred Nobel Drive
HerculesCA94547
USAT: +1 510 724-7000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
7,700
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,021.90 | 60.20 | 0.76% |
CAC 40 | 7,285.86 | 44.11 | -0.60% |
DAX 40 | 21,205.86 | 105.16 | -0.49% |
Dow JONES (US) | 39,142.23 | 527.16 | -1.33% |
FTSE 100 | 8,275.66 | 0.06 | 0.00% |
HKSE | 21,395.14 | 338.16 | 1.61% |
NASDAQ | 16,286.45 | 20.71 | -0.13% |
Nikkei 225 | 34,730.28 | 352.68 | 1.03% |
NZX 50 Index | 12,118.99 | 51.07 | 0.42% |
S&P 500 | 5,282.70 | 7.00 | 0.13% |
S&P/ASX 200 | 7,819.10 | 60.20 | 0.78% |
SSE Composite Index | 3,280.34 | 4.34 | 0.13% |